Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 2476 AL 2490

A Review of Techniques for Biodelivery of Nerve Growth Factor (NGF) to the Brain in Relation to Alzheimer's Disease

Mitra S, Gera R, Linderoth B, Lind G, Wahlberg L, Almqvist P, Behbahani H, Eriksdotter M.

Adv Exp Med Biol. 2021;1331:167-191. doi: 10.1007/978-3-030-74046-7_11.

NGF Released from Blood Cells or Collagen Hydrogels as a Therapeutic Target in Alzheimer's Disease?

Humpel C.

Adv Exp Med Biol. 2021;1331:193-202. doi: 10.1007/978-3-030-74046-7_12.

Alzheimer disease and the periodontal patient: New insights, connections, and therapies

Ryder MI, Xenoudi P.

Periodontol 2000. 2021 Oct;87(1):32-42. doi: 10.1111/prd.12389.

Current druggable targets for therapeutic control of Alzheimer's disease

Gupta GL, Samant NP.

Contemp Clin Trials. 2021 Oct;109:106549. doi: 10.1016/j.cct.2021.106549. Epub 2021 Aug 28.

A systematic review of carbohydrate-based bioactive molecules for Alzheimer's disease

Bajad NG, Swetha R, Gutti G, Singh M, Kumar A, Singh SK.

Future Med Chem. 2021 Oct;13(19):1695-1711. doi: 10.4155/fmc-2021-0109. Epub 2021 Sep 2.

Alzheimer's Disease: Efficacy of Mono- and Combination Therapy. A Systematic Review

Knorz AL, Quante A.

J Geriatr Psychiatry Neurol. 2022 Jul;35(4):475-486. doi: 10.1177/08919887211044746. Epub 2021 Sep 3.

Roles of microglia in Alzheimer's disease and impact of new findings on microglial heterogeneity as a target for therapeutic intervention

Takata K, Ginhoux F, Shimohama S.

Biochem Pharmacol. 2021 Oct;192:114754. doi: 10.1016/j.bcp.2021.114754. Epub 2021 Sep 1.

Effects of Exercise in the Treatment of Alzheimer's Disease: An Umbrella Review of Systematic Reviews and Meta-Analyses

Andrade A, Siqueira TC, D'Oliveira A, Dominski FH.

J Aging Phys Act. 2022 Jun 1;30(3):535-551. doi: 10.1123/japa.2021-0033. Epub 2021 Sep 6.

Extensive metabolism of flavonoids relevant to their potential efficacy on Alzheimer's disease

Xia H.

Drug Metab Rev. 2021 Nov;53(4):563-591. doi: 10.1080/03602532.2021.1977316. Epub 2021 Oct 1.

Exercise Dose and Aerobic Fitness Response in Alzheimer's Dementia: Findings from the FIT-AD Trial

Salisbury D, Mathiason MA, Yu F.

Int J Sports Med. 2022 Sep;43(10):850-858. doi: 10.1055/a-1639-2307. Epub 2021 Sep 7.

The historical evolution of the fornix and its terminology: a review

Dogan E, Gungor A, Dogulu F, Türe U.

Neurosurg Rev. 2022 Apr;45(2):979-988. doi: 10.1007/s10143-021-01635-w. Epub 2021 Sep 8.

Breaker peptides against amyloid-β aggregation: a potential therapeutic strategy for Alzheimer's disease

Ghosh N, Kundu LM.

Future Med Chem. 2021 Oct;13(20):1767-1794. doi: 10.4155/fmc-2021-0184. Epub 2021 Sep 9.

GPR40 Agonist Ameliorate Pathological Neuroinflammation of Alzheimer's Disease via the Modulation of Gut Microbiota and Immune System, a Mini-Review

Chen J, Li Q, Zhu J, Yuan Z, Wang T, Song J.

Neurotox Res. 2021 Dec;39(6):2175-2185. doi: 10.1007/s12640-021-00408-z. Epub 2021 Sep 10.

Effectiveness of the 10 cm(2) Rivastigmine Patch in Taiwanese Patients with Mild-to-Moderate Alzheimer's Dementia: A 48-Week Real-World Observational Study

Chang CC, Chan L, Chou HH, Yang YW, Chen TF, Chen TB, Chen CI, Yang A, Hu CJ.

Adv Ther. 2021 Oct;38(10):5286-5301. doi: 10.1007/s12325-021-01893-6. Epub 2021 Sep 10.

The oxidatively damaged DNA and amyloid-β oligomer hypothesis of Alzheimer's disease

Sanders OD, Rajagopal L, Rajagopal JA.

Free Radic Biol Med. 2022 Feb 1;179:403-412. doi: 10.1016/j.freeradbiomed.2021.08.019. Epub 2021 Sep 8.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias